Comparative study on effects of pentoxifylline, prednisolone and colchicine in experimental alveolitis (Q77758641)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9877283%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Comparative study on effects of pentoxifylline, prednisolone and colchicine in experimental alveolitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9877283%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

1 reference

P Entzian

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9877283%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

U Zähringer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9877283%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M Schlaak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9877283%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

C Gerlach

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9877283%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J Galle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9877283%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

P Zabel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9877283%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9877283%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Immunopharmacology

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9877283%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9877283%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9877283%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

723-735

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9877283%20AND%20SRC:MED&resulttype=core&format=json

Pentoxifylline Inhibits Certain Constitutive and Tumor Necrosis Factor-α-Induced Activities of Human Normal Dermal Fibroblasts

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Results of a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

Inhibition of Collagen Secretion from Bone and Cultured Fibroblasts by Microtubular Disruptive Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

Colchicine Versus Prednisone as Treatment of Usual Interstitial Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

Antiinflammatory and antifibrotic properties of colchicine: implications for idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

Pentoxifylline inhibits the fibrogenic activity of pleural effusions and transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

Colchicine in the treatment of cirrhosis of the liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

Pharmacologic suppression of the neutrophil component of the alveolitis in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

Colchicine in the treatment of pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

Bleomycin-induced pulmonary fibrosis in rats: biochemical demonstration of increased rate of collagen synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

1 reference

7 January 2021

Determinants of progression in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

Determinants of survival in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

Pentoxifylline in treatment of sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900056-3

7 January 2021

10.1016/S0192-0561(98)00056-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9877283%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference